Glaukos Corp.

Glaukos Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
35.26 M
Public Float
27.53 M
Glaukos Corp.
Stock Exchange New York Stock Exchange
EPS
$0.33
Market Cap
$2.84 B
Shares Outstanding
36.4 M
Public Float
34.05 M

Profile

Address
229 Avenida Fabricante
San Clemente California 92672
United States
Employees -
Website http://www.glaukos.com
Updated 07/08/2019
Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B.

Financials

View All

Thomas William Burns
President, Chief Executive Officer & Director
William J. Link
Chairman